MedPath

Can Hormome replacement therapy of menopause improve sleep and quality of life in menopausal women with Fibromyalgia?

Phase 4
Recruiting
Conditions
Fibromyalgia, Menopause, Sleep-Wake disorders
C05.651.324
G08.686.157.500
C10.886
Registration Number
RBR-24bbzs
Lead Sponsor
Hospital de Clínicas da Universidade Federal do Paraná
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Menopausal women with fibromyalgia; with 40 to 60 years old,; and presenting climacteric symptoms

Exclusion Criteria

There will exclude from the study the women who won't be able to comprehend and reply the questionnaires due to their limited cognition or idiomatic; the ones who have presented another associated autoimmune rheumatic disease (systemic lupus erythematosus, rheumatoid arthritis); the patients who have absolute contraindication to the hormone replacement therapy ( breast cancer, endometrium cancer, acute an prior thromboembolism, acute or/ and severe liver disease, acute heart disease and uterine bleeding no diagnosed)

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath